Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
M

Medline Inc
NASDAQ:MDLN

Watchlist Manager
Medline Inc
NASDAQ:MDLN
Watchlist
Price: 39.09 USD 0.54%
Market Cap: $51.4B
Write Note Create Alert Ask AI

Wall St Price Targets

MDLN Price Targets Summary
Medline Inc

Wall Street analysts forecast MDLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDLN is 52.15 USD with a low forecast of 42.42 USD and a high forecast of 65.1 USD.

MDLN Lowest Forecast
42.42 USD
9% Upside
MDLN Average Forecast
52.15 USD
33% Upside
MDLN Highest Forecast
65.1 USD
67% Upside
Lowest Forecast
Price Target
42.42 USD
9% Upside
Average Forecast
Price Target
52.15 USD
33% Upside
Highest Forecast
Price Target
65.1 USD
67% Upside
Medline Inc Competitors:
Price Targets
X
XLO
Xilio Therapeutics Inc
134% Upside
X
XLO
Xilio Therapeutics Inc
134% Upside

Revenue
Forecast

11% / Year
Past Growth
8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 8%.

What are analyst estimates?

Gross Profit
Forecast

13% / Year
Past Growth
8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
13% / Year
Past Growth
8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 5 years is 8%.

What are analyst estimates?

Operating Income
Forecast

31% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
31% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Operating Income has been 31%. The projected CAGR for the next 5 years is 14%.

What are analyst estimates?

Pre-Tax Income
Forecast

117% / Year
Past Growth
38% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
117% / Year
Past Growth
38% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 117%. The projected CAGR for the next 3 years is 38%.

What are analyst estimates?

Net Income
Forecast

123% / Year
Past Growth
25% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
123% / Year
Past Growth
25% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Net Income has been 123%. The projected CAGR for the next 5 years is 25%.

What are analyst estimates?

Continue MDLN Research

Summary
MDLN intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDLN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDLN stock valuation using valuation multiples.
Wall St Estimates
MDLN price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDLN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MDLN's stock price target?
Price Target
52.15 USD

According to Wall Street analysts, the average 1-year price target for MDLN is 52.15 USD with a low forecast of 42.42 USD and a high forecast of 65.1 USD.

What is the Revenue forecast for Medline Inc?
Projected CAGR
8%

Over the last 2 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 8%.

What is the Gross Profit forecast for Medline Inc?
Projected CAGR
8%

Over the last 2 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 5 years is 8%.

What is the Operating Income forecast for Medline Inc?
Projected CAGR
14%

Over the last 2 years, the compound annual growth rate for Operating Income has been 31%. The projected CAGR for the next 5 years is 14%.

What is the Pre-Tax Income forecast for Medline Inc?
Projected CAGR
38%

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 117%. The projected CAGR for the next 3 years is 38%.

What is the Net Income forecast for Medline Inc?
Projected CAGR
25%

Over the last 2 years, the compound annual growth rate for Net Income has been 123%. The projected CAGR for the next 5 years is 25%.

Back to Top
ALPHA SPREAD
Follow us
Join 349,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett